Metabolic Changes in Urine during and after Pregnancy in a Large, Multiethnic Population-Based Cohort Study of Gestational Diabetes

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Sachse, Daniel ^a,b   Sletner, Line ^a,b,c   Mørkrid, Kjersti ^a,b   Jenum, Anne Karen ^a,d   Birkeland, Kåre I ^a,b   Rise, Frode ^a   Piehler, Armin P ^b,e   Berg, Jens Petter ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d OSLO METROPOLITAN UNIVERSITY   (Norway)

^e Furst Medical Laboratory   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LACTOSE;

ADULT; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; METABOLOMICS; NORWAY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; PUERPERIUM; QUANTITATIVE ANALYSIS; URINALYSIS; URINARY EXCRETION;

ADULT; CITRATES; COHORT STUDIES; DIABETES, GESTATIONAL; DISCRIMINANT ANALYSIS; ETHNIC GROUPS; FEMALE; HUMANS; HYPERGLYCEMIA; LACTOSE; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPY; PREGNANCY; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION;

EID: 84871383717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052399     Document Type: Article

References (67)

1. International Diabetes Federation (2011) IDF Diabetes Atlas. Brussels, Belgium: International Diabetes Federation.
2. Beaglehole R, Bonita R, (2012) Tackling NCDs: a different approach is needed. Lancet 379: 1873.
3. Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. nrendo.2012.96 [pii];10.1038/nrendo.2012.96 [doi].
4. Ferrara A (2007) Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30 Suppl 2: S141-S146. 30/Supplement_2/S141 [pii];10.2337/dc07-s206 [doi].
5. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U et al. (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991-2002. 358/19/1991 [pii];10.1056/NEJMoa0707943 [doi].
6. Kim C, Newton KM, Knopp RH, (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25: 1862-1868.
7. HAPO Study Cooperative Research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58: 453-459. db08-1112 [pii];10.2337/db08-1112 [doi].
8. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS et al. (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352: 2477-2486. NEJMoa042973 [pii];10.1056/NEJMoa042973 [doi].
9. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, et al. (2008) Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions. Journal of Clinical Endocrinology & Metabolism 93: 4774-4779.
10. Jenum AK, Sletner L, Voldner N, Vangen S, Morkrid K et al. (2010) The STORK Groruddalen research programme: A population-based cohort study of gestational diabetes, physical activity, and obesity in pregnancy in a multiethnic population. Rationale, methods, study population, and participation rates. Scand J Public Health 38: 60-70. 38/5_suppl/60 [pii];10.1177/1403494810378921 [doi].
11. Jenum AK, Morkrid K, Sletner L, Vangen S, Torper JL et al. (2012) Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol 166: 317-324. EJE-11-0866 [pii];10.1530/EJE-11-0866 [doi].
12. Mørkrid K, Jenum AK, Sletner L, Vardal MH, Waage CW et al. (2012) Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes. Eur J Endocrinol. EJE-12-0452 [pii];10.1530/EJE-12-0452 [doi].
13. Ashwood ER, Knight GJ (2006) Clinical Chemistry of Pregnancy. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. St. Louis, MO, USA: Elsevier Saunders. 2153-2206.
14. Hadden DR, McLaughlin C (2009) Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 14: 66-71. S1744-165X(08)00115-7 [pii];10.1016/j.siny.2008.09.004 [doi].
15. Lain KY, Catalano PM, (2007) Metabolic changes in pregnancy. Clinical Obstetrics and Gynecology 50: 938-948.
16. Naismith DJ (2003) PREGNANCY {pipe} Metabolic Adaptations and Nutritional Requirements. In: Caballero B, editors. Encyclopedia of Food Sciences and Nutrition. Oxford, UK: Academic Press. 4723-4728.
17. Lind T (1980) Clinical Chemistry of Pregnancy. In: Schwartz MK, Latner AL, editors. Advances in Clinical Chemistry. New York, NY, USA: Academic Press, Inc. pp 1-24.
18. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA et al. (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33: 676-682. 33/3/676 [pii];10.2337/dc09-1848 [doi].
19. Alberti KGMM, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Diagnosis and classification of diabetes mellitus- Provisional report of a WHO consultation. Diabetic Medicine 15: 539-553.
20. Nicholson JK, Lindon JC (2008) Systems biology: Metabonomics. Nature 455: 1054-1056. 4551054a [pii];10.1038/4551054a [doi].
21. Schlotterbeck G, Ross A, Dieterle F, Senn H (2006) Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. Pharmacogenomics 7: 1055-1075. 10.2217/14622416.7.7.1055 [doi].
22. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E et al. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2: 2692-2703. nprot.2007.376 [pii];10.1038/nprot.2007.376 [doi].
23. Keun HC, Ebbels TM, Antti H, Bollard ME, Beckonert O et al. (2002) Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. Chem Res Toxicol 15: 1380-1386. tx0255774 [pii].
24. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29: 99-108. 00194.2006 [pii];10.1152/physiolgenomics.00194.2006 [doi].
25. Carraro S, Rezzi S, Reniero F, Heberger K, Giordano G, et al. (2007) Metabolomics applied to exhaled breath condensate in childhood asthma. American Journal of Respiratory and Critical Care Medicine 175: 986-990.
26. Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK (2011) Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 19: 349-359. S0966-842X(11)00095-3 [pii];10.1016/j.tim.2011.05.006 [doi].
27. Spratlin JL, Serkova NJ, Eckhardt SG, (2009) Clinical Applications of Metabolomics in Oncology: A Review. Clinical Cancer Research 15: 431-440.
28. Horgan RP, Clancy OH, Myers JE, Baker PN (2009) An overview of proteomic and metabolomic technologies and their application to pregnancy research. BJOG 116: 173-181. BJO1997 [pii];10.1111/j.1471-0528.2008.01997.x [doi].
29. Diaz SO, Pinto J, Graca G, Duarte IF, Barros AS et al. (2011) Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res 10: 3732-3742. 10.1021/pr200352m [doi].
30. HAPO Study Cooperative Research Grou (2002) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet 78: 69-77. S0020729202000929 [pii].
31. Reynolds WF, Enriquez RG, (2002) Choosing the best pulse sequences, acquisition parameters, postacquisition processing strategies, and probes for natural product structure elucidation by NMR spectroscopy. Journal of Natural Products 65: 221-244.
32. Eaton JW (2002) GNU Octave Manual. Network Theory Limited.
33. R Development Core Team (2010) R: A Language and Environment for Statistical Computing.
34. Barkauskas DA, Rocke DM (2010) A general-purpose baseline estimation algorithm for spectroscopic data. Anal Chim Acta 657: 191-197. S0003-2670(09)01435-4 [pii];10.1016/j.aca.2009.10.043 [doi].
35. Barkauskas DA (2009) FTICRMS: Programs for Analyzing Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry Data.
36. Holmes E, Foxall PJ, Spraul M, Farrant RD, Nicholson JK et al. (1997) 750 MHz 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal 15: 1647-1659. S0731708597000666 [pii].
37. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC, (1995) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67: 793-811.
38. Constantinou MA, Papakonstantinou E, Spraul M, Sevastiadou S, Costalos C, et al. (2005) H-1 NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Analytica Chimica Acta 542: 169-177.
39. Bell JD, Brown JCC, Sadler PJ, (1988) Nmr-Spectroscopy of Body-Fluids. Chemistry in Britain 24: 1021-1024.
40. Wishart DS, Knox C, Guo AC, Eisner R, Young N et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37: D603-D610. gkn810 [pii];10.1093/nar/gkn810 [doi].
41. Wishart DS, (2009) Computational strategies for metabolite identification in metabolomics. Bioanalysis 1: 1579-1596.
42. Petrarulo M, Facchini P, Cerelli E, Marangella M, Linari F, (1995) Citrate in Urine Determined with A New Citrate Lyase Method. Clinical Chemistry 41: 1518-1521.
43. Stacklies W, Redestig H, Scholz M, Walther D, Selbig J, (2007) pcaMethods- a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23: 1164-1167.
44. Mevik B, Wehrens R (2011) pls: Partial Least Squares Regression (PLSR) and Principal Component Regression (PCR).
45. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, et al. (2008) Assessment of PLSDA cross validation. Metabolomics 4: 81-89.
46. Trump S, Laudi S, Unruh N, Goelz R, Leibfritz D (2006) 1H-NMR metabolic profiling of human neonatal urine. MAGMA 19: 305-312. 10.1007/s10334-006-0058-7 [doi].
47. Ishikawa H, Nakashima T, Inaba K, Mitsuyoshi H, Nakajima Y, et al. (1999) Proton magnetic resonance assay of total and taurine-conjugated bile acids in bile. Journal of Lipid Research 40: 1920-1924.
48. Banfi D, Patiny L, (2008) Resurrecting and processing NMR spectra on-line. Chimia 62: 280-281 Available:www.nmrdb.org.
49. Castillo AM, Patiny L, Wist J, (2011) Fast and accurate algorithm for the simulation of NMR spectra of large spin systems. Journal of Magnetic Resonance 209: 123-130.
50. Date JW, (1964) The excretion of lactose and some monosaccharides during pregnancy and lactation. Scand J Clin Lab Invest 16: 589-596.
51. Cox DB, Kent JC, Casey TM, Owens RA, Hartmann PE, (1999) Breast growth and the urinary excretion of lactose during human pregnancy and early lactation: Endocrine relationships. Experimental Physiology 84: 421-434.
52. Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET (2008) Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 21: 195-207. 10.1002/nbm.1176 [doi].
53. Hammar ML, Berg GE, Larsson L, Tiselius HG, Varenhorst E, (1987) Endocrine Changes and Urinary Citrate Excretion. Scandinavian Journal of Urology and Nephrology 21: 51-53.
54. Risberg A, Larsson A, Olsson K, Lyrenas S, Sjoquist M, (2004) Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia. Scandinavian Journal of Clinical & Laboratory Investigation 64: 17-23.
55. Gallery EDM, Ross M, Gyory AZ, (1996) 24-hour urinary creatinine excretion is not altered in human pregnancy. Hypertension in Pregnancy 15: 257-261.
56. Turner E, Brewster JA, Simpson NA, Walker JJ, Fisher J (2007) Plasma from women with preeclampsia has a low lipid and ketone body content-a nuclear magnetic resonance study. Hypertens Pregnancy 26: 329-342. 781394154 [pii];10.1080/10641950701436073 [doi].
57. Kenny LC, Broadhurst D, Brown M, Dunn WB, Redman CW et al. (2008) Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod Sci 15: 591-597. 1933719108316908 [pii];10.1177/1933719108316908 [doi].
58. Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA et al. (2010) Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56: 741-749. 56/4/741 [pii];10.1161/HYPERTENSIONAHA.110.157297 [doi].
59. Horgan RP, Broadhurst DI, Walsh SK, Dunn WB, Brown M et al. (2011) Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy. J Proteome Res 10: 3660-3673. 10.1021/pr2002897 [doi].
60. Graca G, Goodfellow BJ, Barros AS, Diaz S, Duarte IF et al. (2012) UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. Mol Biosyst 8: 1243-1254. 10.1039/c2mb05424h [doi].
61. Dunn WB, Goodacre R, Neyses L, Mamas M (2011) Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis 3: 2205-2222. 10.4155/bio.11.223 [doi].
62. Zhao X, Fritsche J, Wang J, Chen J, Rittig K et al. (2010) Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 6: 362-374. 10.1007/s11306-010-0203-1 [doi].
63. Zhang X, Wang Y, Hao F, Zhou X, Han X et al. (2009) Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res 8: 5188-5195. 10.1021/pr900524z [doi].
64. Dumas ME, Maibaum EC, Teague C, Ueshima H, Zhou B et al. (2006) Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem 78: 2199-2208. 10.1021/ac0517085 [doi].
65. Nicholson G, Rantalainen M, Maher AD, Li JV, Malmodin D et al. (2011) Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol 7: 525. msb201157 [pii];10.1038/msb.2011.57 [doi].
66. Saude EJ, Adamko D, Rowe BH, Marrie T, Sykes BD, (2007) Variation of metabolites in normal human urine. Metabolomics 3: 439-451.
67. Maher AD, Zirah SFM, Holmes E, Nicholson JK, (2007) Experimental and analytical variation in human urine in H-1 NMR spectroscopy-based metabolic phenotyping studies. Analytical Chemistry 79: 5204-5211.